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Objective: The optimal treatment (endovascular/open repair, conduit, configuration) for chronic mesenteric ischemia
(CMI) remains unresolved. This study was designed to review the outcome of patients with CMI treated with antegrade
synthetic aortomesenteric bypass.
Methods: The study was designed as a retrospective review in an academic tertiary care medical center. Patients with CMI
who underwent antegrade synthetic aortomesenteric bypass were identified from a computerized vascular registry (from
January 1987 to January 2001) with antegrade synthetic aortomesenteric bypass as intervention. Outcome measures were
functional outcome (symptom relief, weight gain) and both graft patency (duplex ultrasound/angiography) and survival
rates as determined with life-table analysis.
Results: Forty-seven patients (female, 70%; age, 62  12 years) underwent aortomesenteric bypass (aortoceliac/
aortosuperior mesenteric, n  45; aortosuperior mesenteric, n  2) for CMI (abdominal pain, 98%; weight loss, 83%).
In-hospital mortality rate was 11% (four multiple organ dysfunction, one bowel infarction), mean length of stay was 32
30 days, three patients (6%) were discharged to a nursing home, and one (2%) was discharged home on parenteral
nutrition (duration 4 months). At a mean follow-up period of 31  27 months, all patients had relief of abdominal pain
and 86% had gained weight (at>1 year follow-up: mean ideal body weight 103 22%; versus before surgery: 87 17%;
P < .001). Fourteen patients (34%) had diarrhea at discharge that persisted more than 6 months in 10. One patient had
acute mesenteric ischemia develop from a failed graft (at 20 months), two patients had recurrent CMI develop from
failing grafts (at 46 months and 49 months), and one asymptomatic patient was found to have a failing graft with duplex
ultrasound scan (at 17 months); all grafts were revised. Primary, primary assisted, and secondary 5-year graft patency
rates with life-table analysis were 69% (standard error [SE], 17%), 94% (SE, 7%), and 100%, respectively, and the 5-year
survival rate was 74% (SE, 12%).
Conclusion: Antegrade synthetic aortomesenteric bypass for CMI is associated with good functional outcome and
long-term graft patency. (J Vasc Surg 2002;35:1078-84.)
Chronic mesenteric ischemia is uncommon, although
the incidence rate may be increasing because of better
awareness of associated symptoms and improved screening
for mesenteric arterial occlusive disease with duplex ultra-
sound scan. Open surgical reconstruction has been the
primary treatment, but the reported series documenting
outcome are generally small and many controversies persist
regarding the optimal treatment. These controversies in-
clude the type of revascularization (open surgical repair
versus endovascular), the type of surgical repair (transaortic
endarterectomy versus aortomesenteric bypass grafting, an-
tegrade versus retrograde bypass), and the number of mes-
enteric arteries that should be treated (single versus multi-
ple vessel reconstruction). Furthermore, few reports
document long-term patency after revascularization and
functional outcome with objective measures. This further
complicates evidence-based decision making for patients
with chronic mesenteric ischemia. This study was designed
to determine the long-term functional outcome and graft
patency in patients with chronic mesenteric ischemia
treated at single institution with antegrade synthetic aor-
tomesenteric bypass.
PATIENTS AND METHODS
Seventy-two patients who underwent mesenteric arte-
rial reconstruction at the University of Florida College of
Medicine between January 1987 and January 2001 were
identified with a computerized vascular registry. Of these,
47 patients had undergone revascularization for chronic
mesenteric ischemia with antegrade synthetic aortomesen-
teric bypass and form the basis of this study. Only patients
treated for abdominal pain or otherwise unexplained
weight loss and severe mesenteric arterial occlusive disease
were included. Patients who underwent reconstruction for
acute mesenteric ischemia, asymptomatic mesenteric arte-
rial occlusive disease, and mesenteric arterial aneurysm were
specifically excluded.
The complete medical records of these patients, includ-
ing both inpatient and outpatient notes, were retrospec-
tively reviewed to determine the presenting symptoms,
preoperative evaluation, operative procedure, and periop-
erative outcome. Standard complications were docu-
mented, and organ system failure was determined with a
previously reported scoring system.1 Preoperative mesen-
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teric arteriograms were examined to determine the distri-
bution and degree of mesenteric arterial occlusive disease.
Follow-up clinic records were examined to assess symptom-
atic improvement and functional outcome (weight gain,
dysmotility symptoms, living status), and mesenteric du-
plex ultrasound scan studies or follow-up mesenteric arte-
riograms (done to confirm duplex ultrasound scan studies
suggesting significant graft stenosis or occlusion) were
reviewed to determine graft patency. All patients who un-
derwent mesenteric bypass in our practice are routinely
followed with clinic appointments and duplex ultrasound
scans every 6 months. The duplex scan criteria used to
assess both graft and native artery stenoses or occlusions
have been previously described (50% superior mesenteric
artery stenosis: peak systolic frequency  4.5 kHz; 50%
celiac axis stenosis: peak systolic frequency 4 kHz).2 The
mean follow-up period was 31  27 months (range, 1 to
119 months). Only four patients did not have complete
follow-up, and these were lost to follow-up at an average of
18 months after revascularization.
The mean patient age was 62  12 years, and 33
patients (70%) were female. All patients had symptoms
consistent with chronic mesenteric ischemia, and the dura-
tion of the symptoms before revascularization averaged 12
months (range, 1 to 36 months). Forty-six patients (98%)
reported abdominal pain, and the character of the pain was
postprandial in 85%. Thirty patients (64%) had diarrhea, 10
patients (21%) had constipation, and four were docu-
mented to have delayed gastric emptying with nuclear
imaging studies. Twenty-two patients (47%) had docu-
mented gastric ulcers or gastritis, nine (19%) had under-
gone previous abdominal surgical procedures for treatment
of these symptoms, and 11 (23%) had undergone previous
mesenteric arterial reconstructive procedures (four mesen-
teric bypasses, seven mesenteric angioplasties). Overall, the
patients’ calculated mean ideal body weight was 88  16%
before mesenteric revascularization; 39 patients (83%) had
lost weight before operation, with a mean loss of 35  19
lbs. Seventeen patients (36%) were seen with an exacerba-
tion of their chronic symptoms and underwent urgent
revascularization. Most of these were referred to our insti-
tution with a diagnosis of chronic mesenteric ischemia
supported with characteristic arteriographic findings. Re-
vascularization was performed on an urgent basis because
of the potential to progress to acute mesenteric ischemia
and bowel infarction. No patients had previous bowel
resections for ischemia, but one patient had undergone a
right hepatectomy for infarction caused by mesenteric oc-
clusive disease.
A history of tobacco use was present in 43 patients
(91%), hypertension in 36 (77%), coronary artery disease
(documented by previous myocardial infarction, prior cor-
onary revascularization, or current angina) in 18 (38%),
cerebral vascular occlusive disease in 16 (34%), chronic
obstructive pulmonary disease in 10 (21%), hypercholester-
olemia in five (11%), and diabetes mellitus in two (4%). In
addition, diffuse peripheral arterial occlusive disease as
shown with a prior lower extremity arterial revasculariza-
tion procedure or a history of claudication and reduced
ankle brachial indices was present in 23 patients (49%).
Review of the arteriograms, including the lateral pro-
jections, showed that the overwhelming majority of pa-
tients (94%) had significant stenosis or occlusion of both
the celiac axis and superior mesenteric artery, with 77% of
the patients having significant disease in all three visceral
vessels (Tables I and II). Notably, only one patient had
disease isolated to a single mesenteric vessel (celiac axis).
Atherosclerosis was the cause of the mesenteric arterial
occlusive disease in all but one patient (age, 35 years) who
was suspected of having Takayasu’s arteritis.
All patients underwent antegrade aortomesenteric arte-
rial bypass with a synthetic bypass graft originating from the
supraceliac aorta. Forty-five patients had bifurcated grafts
to the celiac axis and the superior mesenteric artery, and
two patients had antegrade bypass to the superior mesen-
teric artery alone. One of the latter two patients had mini-
mal occlusive disease of the celiac axis, and one had an
asymptomatic occlusion of the celiac limb of a previous
antegrade aorta celiac/superior mesenteric artery bypass
done with greater saphenous vein and had recurrent symp-
toms develop only when the superior mesenteric artery
limb thrombosed. Eight patients also had repair of the
inferior mesenteric artery (bypass with vein, n  2; reim-
plantation/patch repair, n  6), and three patients had
other concurrent vascular reconstructive procedures (aor-
tobifemoral bypass for aortoiliac occlusive disease in two,
thrombectomy of an occluded aortobifemoral bypass graft
limb in one). Operative length was 5.3  1.6 hours, and
estimated blood loss was 1216  1813 mL.
The technique for antegrade synthetic aortomesenteric
bypass has been previously described3 and can be briefly
summarized. The supraceliac aorta and the origin of the
celiac axis are exposed with division of the crus of the
diaphragm, and the branches of the celiac axis are individ-
ually isolated in the gastrohepatic ligament. The proximal
Table I. Preoperative mesenteric arteriogram
Artery Occlusion Stenosis  50% Stenosis  50%
Celiac axis 22 (47%) 24 (51%) 1 (2%)
Superior mesenteric 25 (53%) 20 (43%) 2 (4%)
Inferior mesenteric 28 (60%) 10 (21%) 9 (19%)
Table II. Significant mesenteric occlusive lesions
(occlusion or 50% stenosis) with preoperative
arteriography
Artery Patients
Celiac axis  superior mesenteric  inferior
mesenteric
36 (77%)
Celiac axis  superior mesenteric 8 (17%)
Celiac axis alone 1 (2%)
Celiac axis  inferior mesenteric 1 (2%)
Superior mesenteric  inferior mesenteric 1 (2%)
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portion of the superior mesenteric artery then is isolated
just distal to the pancreas, either after inferior retraction of
the stomach or through the gastrocolic ligament. The
bypass is done with either a 12  6–mm or 12  7–mm
bifurcated Dacron graft. Supraceliac aortic control is ob-
tained with a specially designed partial occlusion clamp, and
the proximal anastomosis is done end-to-side with the
limbs of the graft oriented on top of each other. The
superior limb is used for the celiac axis bypass, and the
inferior limb, used for the superior mesenteric artery by-
pass, is tunneled deep to the pancreas. The superior mes-
entery artery anastomosis is done end-to-side, and the
celiac axis anastomosis is done end-to-end.
Values are expressed as mean  standard deviation
where appropriate. Patient survival and graft patency rates
were determined with recommended life-table methods.4
Preoperative and postoperative percent ideal body weights
were compared with a paired t test, and a P value of less
than .05 was accepted as significant.
RESULTS
Thirty-one patients (66%) had significant complica-
tions develop after antegrade prosthetic aortomesenteric
arterial bypass, and 30 (64%) had multiple organ dysfunc-
tion develop with the defined criteria (Table III). Ten
patients needed secondary procedures during the postop-
erative period (tracheostomy, n  4; “second look” lapa-
rotomy, n  3; femorofemoral bypass, n  2; feeding
jejunostomy, n  1; abscess drainage, n  1). No patient
had graft occlusion, and only one patient had bowel necro-
sis. Intensive care unit length of stay was 18 22 days, and
total hospital length of stay was 32 30 days. Five patients
(10.6%) died before hospital discharge (postoperative days,
17, 20, 22, 28, and 121), four from multiple organ dys-
function and one from bowel infarction. Two of the pa-
tients who died of multiple organ dysfunction had worsen-
ing of their symptoms and underwent urgent mesenteric
revascularization, and two had preoperative chronic renal
insufficiency and died of renal failure after a decision to
discontinue hemodialysis. All of these patients had patent
mesenteric bypass grafts confirmed with mesenteric duplex
ultrasound scan studies or autopsy. The remaining patient
had heparin-induced thrombocytopenia develop and was
found at exploratory laparotomy to have extensive small
bowel and colon infarction incompatible with life despite a
patent mesenteric bypass.
Thirty-three patients (79%) were discharged home, six
(14%) were discharged to short-term rehabilitation facili-
ties, and three (7%) were discharged to long-term care
facilities. The six patients discharged to rehabilitation facil-
ities all subsequently returned home. In contrast, two of the
three patients sent to long-term care facilities died of pneu-
monia at 3 and 5 months after hospital discharge, and the
third patient was alive but still in a long-term care facility at
21 months after discharge. Six patients died during long-
term follow-up: one of myocardial infarction, one of con-
gestive heart failure, and four of unknown causes. Thus,
survival rate with life-table analysis at 5 years was 74%
(standard error [SE], 12%; Fig 1; Appendix 1, online only).
All patients had relief of preoperative abdominal pain after
mesenteric bypass, and all but one were able to tolerate
enteral nutrition by 18  19 days (range, 4 to 115 days)
after surgery. The one patient who could not tolerate
enteral feedings had a combination of delayed gastric emp-
tying and diarrhea and was discharged home on total
parenteral nutrition. After 4 months, this patient’s condi-
tion improved to the point that she could tolerate oral
feedings, and her dysmotility symptoms were significantly
improved at 2 years of follow-up. A total of 14 patients
(33%) had significant postoperative diarrhea, nine of whom
had similar preoperative symptoms. All patients with post-
operative diarrhea reported a decreased number of bowel
movements per day over time; however, 10 patients (24%)
continued to report diarrhea for longer than 6 months. At
1 year after revascularization, 32 of 37 surviving patients
(86%) with documented weights had actually gained
weight. The exceptions had either severe comorbidities or
severe diarrhea. Furthermore, mean percent ideal body
weight increased from 87 17% to 103 23% (P .004)
Table III. Complications after synthetic antegrade
mesenteric arterial bypass
Complication Patients
Multiple organ dysfunction 30 (64%)
Mechanical ventilation 48 hours 25 (53%)
Sepsis 22 (47%)
Pneumonia 13 (28%)
Renal failure necessitating dialysis 5 (11%)
Urinary tract infection 9 (19%)
Myocardial infarction 1 (2%)
Significant arrhythmia 3 (6%)
Gastrointestinal bleeding 2 (4%)
Fascial dehiscence 1 (2%)
Fig 1. Patient survival rate after antegrade synthetic aortomesen-
teric artery bypass is shown with life-table analysis method. Num-
bers of patients at risk at beginning of interval are provided. Broken
lines reflect SE more than 10%.
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among those with documented weights. All patients who
returned home were ambulatory and reported a return to
baseline functional status.
Three patients had recurrent symptoms of mesenteric
ischemia develop during follow-up. One patient had signs
and symptoms of acute mesenteric ischemia 20 months
after revascularization. The patient was found to have is-
chemic yet viable bowel at the time of emergency laparot-
omy and an occluded aortoceliac/superior mesenteric ar-
tery bypass graft. Notably, the patient had undergone
repair of the inferior mesenteric artery at the original revas-
cularization, and this remained patent. The patient under-
went graft thrombectomy and revision of both the celiac
and the superior mesenteric artery anastomoses and re-
mains asymptomatic with normal mesenteric duplex ultra-
sound scan studies 17 months later. Two additional pa-
tients had less severe recurrent symptoms and abnormal
mesenteric duplex ultrasound scan studies at 46 and 49
months. Arteriography in one patient revealed a high-grade
stenosis of the hepatic artery anastomosis, and percutane-
ous angioplasty of that lesion resulted in good long-term
symptom relief and subsequent normal duplex ultrasound
scan studies. Arteriography in the second patient showed a
high-grade stenosis of the superior mesenteric artery anas-
tomosis that was repaired surgically, again with good long-
term symptom relief and normal mesenteric duplex ultra-
sound scan studies. One additional patient without
symptoms had an abnormal mesenteric duplex ultrasound
scan study at 17 months of follow-up, and angiography
showed both a kink of the celiac limb and a possible
pseudoaneurysm of the superior mesenteric artery anasto-
mosis. The kink in the celiac limb of the bypass and the
superior mesenteric artery lesion, found to be a true aneu-
rysm of the posterior wall of the superior mesenteric artery,
were repaired surgically, and this patient remains asymp-
tomatic and subsequently has had normal mesenteric du-
plex ultrasound scan studies. Thus, primary, primary as-
sisted, and secondary patency rates were 69% (SE, 17%),
96% (SE, 7%), and 100%, respectively, at 5 years with
life-table analysis (Figs 2, 3, and 4; Appendixes 2, 3, and 4,
online only).
DISCUSSION
The results of this study suggest that the treatment of
chronic mesenteric ischemia with synthetic antegrade aor-
tomesenteric bypass is associated with significant operative
mortality and incidence of complication rates. Fortunately,
the long-term outcomes as assessed with graft patency,
functional status, symptomatic relief, and survival are all
quite good. These findings are similar to those reported
from other recent studies of the surgical treatment of
chronic mesenteric ischemia, particularly those in which
bypass graft patency was documented by objective
means.5-14 Reported operative mortality rate has ranged
from 4% to 12%, long-term primary graft patency rate from
73% to 88%, rate of recurrence of symptoms long term from
3% to 11%, and 5-year survival rate after revascularization
from 61% to 71%. In contrast, early graft thrombosis has
been reported to occur in up to 6% of patients, and com-
plications of recurrent mesenteric ischemia accounted for
up to 33% of long-term deaths, neither of which were seen
in this series. However, the relatively small number of
patients reported in these series and the variety of surgical
treatments preclude recommendation of one type of surgi-
cal therapy for the treatment of chronic mesenteric is-
chemia on the basis of observed differences in results.
Extensive functional outcome after open revasculariza-
tion for chronic mesenteric ischemia has not been previ-
ously investigated to our knowledge. Notably, all patients
had immediate relief of preoperative abdominal pain, as has
been reported by other investigators,5-14 and most gained
Fig 2. Primary graft patency rate after antegrade synthetic aor-
tomesenteric artery bypass is shown with life-table analysis
method. Numbers of patients at risk at beginning of interval are
provided. Broken lines reflect SE more than 10%.
Fig 3. Primary assisted graft patency rate after antegrade syn-
thetic aortomesenteric artery bypass is shown with life-table anal-
ysis method. Numbers of patients at risk at beginning of interval
are provided.
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significant weight, with the exceptions being those patients
with significant comorbidities or significant diarrhea. In
addition, most of those patients discharged were ambula-
tory and returned home to normal activities. The only
consistently reported chronic postoperative problem was
diarrhea that, unfortunately, occurred in approximately
25% of the survivors. The cause of this dysmotility problem
is unclear; however, it was more common in patients with
preoperative diarrhea and appeared unaffected by the ade-
quacy of small bowel perfusion. Furthermore, it has been
our anecdotal experience that it is not caused by enteric
bacterial overgrowth because patients have been refractory
to antibiotics.
We have chosen to treat patients with chronic mesen-
teric ischemia with antegrade synthetic multivessel aor-
tomesenteric bypass on the basis of the relative simplicity of
the procedure and on previously published reports suggest-
ing the possible superiority of this approach. Johnston et al8
reported a higher failure rate with retrograde bypasses done
for chronic mesenteric ischemia when compared with pro-
grade grafts. Furthermore, McAfee et al11 reported higher
patient survival and graft patency rates in patients who
underwent complete mesenteric revascularization com-
pared with those in whom revascularization was incom-
plete. However, none of these differences was statistically
significant, and Foley et al6 reported good long-term re-
sults in patients treated for chronic mesenteric ischemia
with retrograde revascularization of the superior mesen-
teric artery alone. Although results for retrograde single-
vessel bypass and antegrade multivessel revascularization
appear similar, two potential problems with the retrograde
single bypass approach raise concern. First, the infrarenal
aorta, which is the inflow site for the retrograde bypass, is
commonly diseased in patients with chronic mesenteric
ischemia, and 25% of the patients in the series by Foley et al6
needed aortic reconstruction as part of the mesenteric
revascularization. Previous studies have suggested that
combining mesenteric reconstruction with other vascular
procedures results in significantly increased postoperative
morbidity rate,11 as has been our anecdotal experience.
Second, and potentially more important, the failure of a
single mesenteric bypass may be more likely to be associ-
ated with severe mesenteric ischemia than the failure of one
of multiple mesenteric bypasses. Two of the three patients
in the series of Foley et al6 with late bypass graft failure died
of complications of acute mesenteric ischemia. In contrast,
no patient in the series by McMillan et al12 (where com-
plete revascularization was the goal) died of mesenteric
ischemia because of late bypass graft failure and two thirds
of the late graft occlusions were asymptomatic. Similarly, in
this study, only the patient who had occlusion develop of
both limbs of an antegrade aortoceliac/superior mesenteric
artery bypass had acute mesenteric ischemia develop, and
her bowel remained viable, likely because of the continued
patency of a repaired inferior mesenteric artery. The other
two patients in whom stenosis of single limbs of antegrade
multivessel bypasses developed had only mild symptoms
before graft repair.
Alternative treatments for patients with visceral artery
occlusive disease, such as balloon angioplasty, must be
compared with contemporary series of open surgical revas-
cularization, including this study. Most of the studies doc-
umenting the efficacy of the endovascular approach in this
setting are comprised of small numbers of patients with
limited follow-up.15-17 However, several observations are
consistent in this limited experience. First, presumably be-
cause of the difficulty associated with endovascular treat-
ment of occluded visceral vessels, most cases in the pub-
lished series have involved stenotic rather than occluded
vessels and are primarily single-vessel revascularizations of
the superior mesenteric artery. Thus, the extent of mesen-
teric revascularization is less complete than most open
surgical series. Second, and potentially because of this less
complete revascularization, the results after endovascular
treatment of patients with chronic mesenteric ischemia are
marginal relative to open repair. Treatment-related mortal-
ity rate has ranged from 5% to 11%, initial symptomatic
improvement has been achieved in only 70% to 80% of
patients, and recurrent symptoms or restenosis have oc-
curred in 20% to 30% of patients at 2 to 3 years of follow-
up.15-17 Notably, Kasirajan et al17 compared endovascular
and open surgical repair in patients with chronic mesenteric
ischemia treated at the same institution and reported that
posttreatment mortality and incidence of complication
rates were the same, although the incidence rate of systemic
complications was higher in the open surgical group.
Antegrade synthetic aortomesenteric bypass is a rela-
tively straightforward procedure in most clinical settings
and facilitates multivessel revascularization. The procedure
is both effective and durable as reflected by long-term
patient survival and freedom from symptoms of recurrent
mesenteric ischemia. Furthermore, objective determina-
tion of graft patency is possible in the clinic setting with
mesenteric duplex ultrasound scanning, thereby potentially
Fig 4. Secondary graft patency rate after antegrade synthetic aor-
tomesenteric artery bypass is shown with life-table analysis
method. Numbers of patients at risk at beginning of interval are
provided.
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facilitating the identification of graft stenoses before graft
failure and the development of acute mesenteric ischemia.
However, the procedural associated morbidity and mortal-
ity rates remain significant, and further improvements in
outcome must be achieved by reducing these adverse peri-
operative events in this difficult group of patients.
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DISCUSSION
Dr Frank W. LoGerfo (Boston, Mass). Dr Jimenez, thank
you for this excellent presentation. I note in your experience,
which has been similar to ours, the long duration of symptoms
prior to these patients coming to surgery and the confusing nature
of their symptoms. In your group, how many presented with a
classic story of postprandial pain as opposed to other gastrointes-
tinal symptoms? Secondly, when you do this operation, the most
common one being bypass to the celiac or hepatic and the superior
mesenteric artery, do you have any preference as to which vessel to
reconstruct first, and are you using complete aortic occlusion or a
side-biting clamp on that aorta?
Dr Javier Jimenez. Eighty-five percent of our patients re-
ported classic postprandial-type pain that worsened after meals along
with other symptoms of abdominal pain and diarrhea and such.
As far as the reconstruction, we preferably reconstruct the
superior mesenteric artery, but again 45 of these bypasses were
both to the celiac and superior mesenteric vessels.
The occlusion method we use at the supraceliac aorta prefer-
entially is a partial occlusion clamp.
Dr Zwolak (Lebanon, NH). That was a very nice paper. I was
wondering, in view of your excellent patency, about the actual
utility and value of these duplex scans every 6 months, whether you
really think it is important and valuable to get them. I think that in
only one patient did the scan pick up some abnormality, in a patient
who was presumably asymptomatic. What value is there to getting
these scans every 6 months?
Dr Jimenez. Dr Zwolak, that is an excellent point and one
that we have brought up. Yes, only one patient out of the 47 was
asymptomatic and caught on surveillance duplex. This could be
seen as a success or it could be seen as overuse of utilities, but in a
large proportion of our patients, as you saw, 25% of them continue
to complain of diarrhea, and, at times, this mesenteric duplex helps
to distinguish whether this diarrhea is simply a postoperative
phenomenon that continues on and their bypass is patent or
whether there is recurrence of disease. That is where we stand with
our duplex examination.
Dr A. David Drezner (Hartford, Conn). I notice that eight
patients had inferior mesenteric artery bypasses also. I am wonder-
ing what the indication was for that and what the patency rate was
for that particular bypass.
Dr Jimenez. Sir, we tried to vascularize as many of the
mesenteric vessels as possible. In those eight patients, the simple
answer is it was easy to vascularize the inferior mesenteric artery
because the infrarenal aorta is soft, technically simple, and did not
prolong the operation an extensive period of time. We do see it as
valuable. We do have one patient that recurred acutely. That bypass
was occluded. That patient did though also have revascularization
of the inferior mesenteric artery, and we believe that patient’s
bowel was maintained for that short period of time due to that
revascularization. Summarizing this answer, we try to revascularize
as many inferior mesenteric arteries as possible but, on the other
hand, without prolonging the operation too much as long as it is
technically feasible.
Dr Robert Patterson (Providence, RI). Do you have any
information on associated renovascular disease with this proce-
dure? How many times did you deal with renovascular disease, and
how did you manage this disease when it was discovered? Did renal
artery involvement have any effect on the perioperative morbidity
and mortality of your patients?
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Dr Jimenez. There were only one or two patients in this
series with associated renovascular disease. In this series, there is
only one patient who had revascularization of their renal artery
disease, so there is only one patient to be able to give you any
significant data on that.
Dr David Brewster (Boston, Mass). Can you just tell us
briefly about what operative incision and approach you use for your
procedures? Secondly, many of these patients have orificial disease,
and in those circumstances, we have often found transaortic
thromboendarterectomy to be a useful method. Were all of your
operations bypass or did you have any experience with endarterec-
tomy, and what are your views on that approach?
Dr Jimenez. The first question is the approach we used, and
the approach we use is a transperitoneal approach either through a
midline or a bilateral subcostal incision.
The second question, as far as endarterectomy, we have a very
limited experience with endarterectomy, mostly from our senior
mentor who does not like that approach.
Unidentified speaker. I believe seven of your patients had
undergone prior angioplasty. What are your criteria for selecting
angioplasty versus bypass?
Dr Jimenez. At our institution, our angiographers are very
conservative as far as angioplasting these lesions, and our experi-
ence is small as far as angioplasting these lesions. The criteria we use
are, one, a patient who is extremely debilitated and we feel that
their mortality from surgery is going to be high and this may be a
bridge to improve their overall nutritional state. The other
indication that we may use is those patients in whom the chronic
mesenteric ischemia is not totally confirmed and in this case an
attempt at angioplasty to see if there is any relief of symptoms.
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